| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.2 | 0.001 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.088 | 0.08 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.078 | 0.08 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.083 | 0.1 |